Skip to content
Clinical Trials – home

Uniwersytecki Szpital Kliniczny W Bialymstoku

Verified siteinfo

Poland Ul. Marii Curie-Sklodowskiej 24a, 15-276 Bialystok, Poland

  • 60 trials recruiting
  • Non-small cell lung cancer · Cardiac failure · Obesity
  • Adults and children

About Specializations

Uniwersytecki Szpital Kliniczny W Bialymstoku in Bialystok, Poland specialises in clinical trials of conditions such as Non-small cell lung cancer, Cardiac failure, Obesity, Pulmonary hypertension, and other specialisations. This site conducts important research.

Main research areas of the site

Obesity and Overweight Management

The medical center is at the forefront of research in the management of obesity and overweight conditions. Through innovative studies, the center is exploring new therapeutic approaches to improve patient outcomes and enhance quality of life.

  • Novel therapeutic interventions
  • Comprehensive weight management programs
  • Patient-centered care strategies

By focusing on the efficacy and safety of emerging treatments, the center is contributing significantly to the development of effective weight management solutions.

Osteoarthritis Research

Specializing in osteoarthritis, particularly of the knee, the center is dedicated to advancing understanding and treatment of this prevalent condition. Research efforts are directed towards innovative therapies that aim to alleviate pain and improve joint function.

  • Advanced pain management techniques
  • Joint preservation strategies
  • Rehabilitation and physical therapy advancements

The center's work in this area is pivotal in developing new standards of care for osteoarthritis patients, enhancing their mobility and quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Marii Curie-Sklodowskiej 24a15-276 BialystokPoland
Recruiting now
60 trials
Conditions studied
91
Partner status
Verified site

More sites in BialystokPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

155 clinical trials

Obesity+2

Recruiting

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC

Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:BioNTech SE

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Schizophrenia

Recruiting

Study of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evenamide
  • Sponsor:Newron Pharmaceuticals S.p.A.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE

Crohn's disease

Recruiting

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Carboplatin
  • Sponsor:Innate Pharma

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.